200 related articles for article (PubMed ID: 34938313)
1. Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer.
Xu F; Tang Q; Wang Y; Wang G; Qian K; Ju L; Xiao Y
Front Genet; 2021; 12():758612. PubMed ID: 34938313
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer.
Zhao K; Zhang Q; Zeng T; Zhang J; Song N; Wang Z
Transl Androl Urol; 2021 Mar; 10(3):1229-1240. PubMed ID: 33850758
[TBL] [Abstract][Full Text] [Related]
3. Identification of necroptosis-related long non-coding RNAs prognostic signature and the crucial lncRNA in bladder cancer.
Sun YF; Chen L; Xia QJ; Wang TH
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10217-10234. PubMed ID: 37269345
[TBL] [Abstract][Full Text] [Related]
4. Construction and Validation of a Prognostic Model Based on Pyroptosisrelated Genes in Bladder Cancer.
Shen C; Han C; Li Z; Yan Y; Li C; Chen H; Fan Z; Hu H
Comb Chem High Throughput Screen; 2023 Oct; ():. PubMed ID: 37849225
[TBL] [Abstract][Full Text] [Related]
5. An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients.
Zhu G; Xia H; Tang Q; Bi F
Cancer Cell Int; 2021 Mar; 21(1):166. PubMed ID: 33712026
[TBL] [Abstract][Full Text] [Related]
6. An Unfolded Protein Response Related Signature Could Robustly Predict Survival Outcomes and Closely Correlate With Response to Immunotherapy and Chemotherapy in Bladder Cancer.
Zhang F; Feng D; Wang X; Gu Y; Shen Z; Yang Y; Wang J; Zhong Q; Li D; Hu H; Han P
Front Mol Biosci; 2021; 8():780329. PubMed ID: 35004850
[No Abstract] [Full Text] [Related]
7. A novel prognostic model based on cellular senescence-related gene signature for bladder cancer.
Luo L; Li F; Gong B; Xi P; Xie W
Front Oncol; 2022; 12():937951. PubMed ID: 36505846
[TBL] [Abstract][Full Text] [Related]
8. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
Ren L; Yang X; Liu J; Wang W; Liu Z; Lin Q; Huang B; Pan J; Mao X
Cancer Cell Int; 2023 May; 23(1):85. PubMed ID: 37158958
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Signature Development on the Basis of Macrophage Phagocytosis-Mediated Oxidative Phosphorylation in Bladder Cancer.
Qu G; Xu Y; Lu Z; Nie H; Tang C; Hou J; Wen X
Oxid Med Cell Longev; 2022; 2022():4754935. PubMed ID: 36211821
[TBL] [Abstract][Full Text] [Related]
10. A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer.
Wang W; Zhang X; Jiang S; Xu P; Chen K; Li K; Wang F; Le X; Zhang K
Front Immunol; 2023; 14():1187286. PubMed ID: 37691944
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the Lipid Metabolism in Bladder Cancer to Guide Clinical Therapy.
Yang YY; Hong SY; Xun Y; Liu CQ; Sun JX; Xu JZ; Xu MY; An Y; He D; Xia QD; Wang SG
J Oncol; 2022; 2022():7679652. PubMed ID: 36131793
[TBL] [Abstract][Full Text] [Related]
12. A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer.
Zhang C; Gou X; He W; Yang H; Yin H
Cancer Cell Int; 2020; 20():177. PubMed ID: 32467671
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Analysis of Differentially Expressed DNA Damage Repair Genes in Bladder Cancer.
Yang Y; Yu J; Xiong Y; Xiao J; Dai D; Zhang F
Pathol Oncol Res; 2022; 28():1610267. PubMed ID: 35685866
[TBL] [Abstract][Full Text] [Related]
14. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
15. An epithelial-mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer.
Tong H; Li T; Gao S; Yin H; Cao H; He W
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33289830
[TBL] [Abstract][Full Text] [Related]
16. Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer.
Liu J; Ma H; Meng L; Liu X; Lv Z; Zhang Y; Wang J
Front Mol Biosci; 2021; 8():675651. PubMed ID: 34095228
[No Abstract] [Full Text] [Related]
17. A novel signature of aging-related genes associated with lymphatic metastasis for survival prediction in patients with bladder cancer.
Zhu Z; Li X; Liu D; Li Z
Front Oncol; 2023; 13():1140891. PubMed ID: 37441420
[TBL] [Abstract][Full Text] [Related]
18. A panel of 8-lncRNA predicts prognosis of breast cancer patients and migration of breast cancer cells.
Zhu L; Cui K; Weng L; Yu P; Du Y; Zhang T; Liu H; Li B; Ma W
PLoS One; 2021; 16(6):e0249174. PubMed ID: 34086679
[TBL] [Abstract][Full Text] [Related]
19. Construction and validation of a metabolism-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer.
Shen C; Bi Y; Chai W; Zhang Z; Yang S; Liu Y; Wu Z; Peng F; Fan Z; Hu H
BMC Med Genomics; 2023 Oct; 16(1):264. PubMed ID: 37880682
[TBL] [Abstract][Full Text] [Related]
20. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
Fang Q; Chen H
Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]